T N Krasnova Selected Research

T N Krasnova Research Topics

Disease

4	Nephritis 01/2015 - 01/2002
3	Hematuria 01/2012 - 01/2000
3	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2012 - 01/2000
2	Venous Thrombosis (Deep-Vein Thrombosis) 03/2021 - 01/2020
2	Inflammation (Inflammations) 03/2021 - 01/2020
2	COVID-19 03/2021 - 01/2020
2	Coronavirus Infections 03/2021 - 01/2020
2	Pneumonia (Pneumonitis) 03/2021 - 01/2020
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2017 - 01/2014
2	Chronic Hepatitis C 01/2015 - 01/2013
2	Lupus Nephritis 01/2015 - 01/2012
2	Insulin Resistance 01/2013 - 01/2012
2	Obesity 01/2013 - 01/2012
2	IGA Glomerulonephritis (IGA Nephropathy) 01/2012 - 01/2002
2	Glomerulonephritis 01/2007 - 01/2002
2	Disease Progression 01/2002 - 01/2000
2	Proteinuria 01/2002 - 01/2000
1	Chronic Cough 03/2021
1	Viral Pneumonia 03/2021
1	Fever (Fevers) 03/2021
1	Dyspnea (Shortness of Breath) 03/2021
1	Lung Injury 01/2020
1	Cytokine Release Syndrome 01/2020
1	Thromboembolism 01/2020
1	Thrombosis (Thrombus) 01/2020
1	Infections 11/2018
1	Hepatolenticular Degeneration (Wilson's Disease) 11/2018
1	Autoimmune Diseases (Autoimmune Disease) 01/2017
1	Neutropenia 01/2017
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2015
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2014
1	Albuminuria 01/2013
1	Chronic Disease (Chronic Diseases) 01/2012
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2012
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2012
1	Chronic Renal Insufficiency 01/2012
1	Hepatitis 01/2007
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2007
1	Sclerosis 01/2002
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2002
1	Tics (Tic) 01/2002
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2000

Drug/Important Bio-Agent (IBA)

2	C-Reactive ProteinIBA 03/2021 - 01/2020
2	fibrin fragment D (D-dimer)IBA 03/2021 - 01/2020
2	CytokinesIBA 01/2020 - 01/2007
2	Antiviral Agents (Antivirals)IBA 11/2018 - 01/2013
2	Interleukin-10 (Interleukin 10)IBA 01/2015 - 01/2015
2	Interleukin-6 (Interleukin 6)IBA 01/2015 - 01/2007
2	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 01/2014 - 01/2012
2	Nitric Oxide Synthase (NO Synthase)IBA 01/2014 - 01/2012
2	Genetic Markers (Genetic Marker)IBA 01/2013 - 01/2007
2	Immunoglobulin A (IgA)IBA 01/2012 - 01/2002
2	CreatinineIBA 01/2002 - 01/2000
1	Oxygen (Dioxygen)IBA 03/2021
1	ruxolitinibIBA 03/2021
1	secukinumabIBA 03/2021
1	Colchicine FDA LinkGeneric 03/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020
1	Hormones (Hormone)IBA 01/2020
1	Methylprednisolone FDA LinkGeneric 01/2020
1	SteroidsIBA 01/2020
1	ChemokinesIBA 01/2020
1	InterferonsIBA 11/2018
1	ChromatinIBA 01/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017
1	AutoantibodiesIBA 01/2017
1	AntibodiesIBA 01/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017
1	Antimicrobial PeptidesIBA 01/2017
1	Hemostatics (Antihemorrhagics)IBA 01/2014
1	Glycoproteins (Glycoprotein)IBA 01/2014
1	Fibrinogen (Factor I)FDA Link 01/2014
1	Factor XIII (Coagulation Factor XIII)IBA 01/2014
1	Proteins (Proteins, Gene)FDA Link 01/2014
1	Plasminogen InactivatorsIBA 01/2014
1	NADH oxidaseIBA 01/2014
1	Integrin alpha2IBA 01/2014
1	Integrin beta3 (GPIIIa)IBA 01/2014
1	Uric Acid (Urate)IBA 01/2013
1	Biological ProductsIBA 01/2013
1	EnzymesIBA 01/2013
1	Interferon LambdaIBA 01/2013
1	C-PeptideIBA 01/2013
1	Insulin (Novolin)FDA Link 01/2013
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2012
1	Rituximab (Mabthera)FDA Link 01/2007
1	Monoclonal AntibodiesIBA 01/2007
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 01/2007
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2002
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2002
1	Cytostatic AgentsIBA 01/2002

Therapy/Procedure

7	Therapeutics 03/2021 - 01/2000
1	Aftercare (After-Treatment) 03/2021